Bronchogenic carcinoma: new drugs available for study.
D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001374:Azacitidine / Q000097:blood / Q000627:therapeutic use; D002283:Carcinoma, Bronchogenic / Q000188:drug therapy*; D002865:Chromomycins / Q000627:therapeutic use; D003498:Cyclic P-Oxides / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D006207:Half-Life; D006801:Humans; D007700:Kinetics; D008175:Lung Neoplasms / Q000188:drug therapy*; D009942:Organometallic Compounds / Q000627:therapeutic use; D009943:Organophosphorus Compounds / Q000627:therapeutic use; D010078:Oxazines / Q000627:therapeutic use; D010984:Platinum / Q000627:therapeutic use
D000970:Antineoplastic Agents; D002865:Chromomycins; D003498:Cyclic P-Oxides; D009942:Organometallic Compounds; D009943:Organophosphorus Compounds; D010078:Oxazines; D010984:Platinum; D003520:Cyclophosphamide; D001374:Azacitidine